Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine

<p>Hydroxychloroquine (HCQ), the hydroxyl derivative of chloroquine (CQ), is widely used in the treatment of rheumatological conditions (systemic lupus erythematosus, rheumatoid arthritis) and is being studied for the treatment and prevention of COVID-19. Here, we investigate through mathemati...

Full description

Bibliographic Details
Main Authors:	Whittaker, DG, Capel, RA, Hendrix, M, Chan, XHS, Herring, N, White, NJ, Mirams, GR, Burton, R-AB
Format:	Journal article
Language:	English
Published:	The Royal Society 2021

Similar Items

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine
by: Dominic G. Whittaker, et al.
Published: (2021-04-01)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
by: White, NJ, et al.
Published: (2020)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01)

Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
by: Ai-Ling Tian, et al.
Published: (2021-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease
by: Julia Prinz, et al.
Published: (2023-06-01)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
by: Jacob A. Lebin, et al.
Published: (2020-07-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021-01-01)

The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
by: Carolina Pereira Fernandes, et al.
Published: (2022-01-01)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
by: Vincent Gies, et al.
Published: (2020-07-01)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
by: Lotery, A, et al.
Published: (2018)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
by: Yusuf, IH, et al.
Published: (2018)

Chloroquine and Hydroxychloroquine: Potentially Inappropriate Medications for Older Adults?
by: Milton Gorzoni
Published: (2024-10-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
by: Carlos Enrique Salgado-Fuentes
Published: (2021-05-01)

Prophylactic Effect of Chloroquine and Hydroxychloroquine on COVID-19 Treatment
by: Amin Ataie, et al.
Published: (2022-04-01)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
by: Timothy J. Kamp, et al.
Published: (2020-06-01)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
by: Elie Naddaf, et al.
Published: (2021-02-01)

The mechanism of chloroquine/hydroxychloroquine and its application in stomatological diseases
by: LIN Lin, et al.
Published: (2021-03-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
by: Rosa Camila Lucchetta, et al.
Published: (2020-04-01)

Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variability
by: Yunendah Nur Fuadah, et al.
Published: (2023-10-01)

Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential.
by: Capel, R, et al.
Published: (2015)

Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine
by: Seidu A. Richard, et al.
Published: (2020-01-01)

Hydroxychloroquine and chloroquine for COVID-19 infection. Rapid systematic review
by: Rafael Leite Pacheco, et al.
Published: (2020-03-01)

Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma
by: Archana Bhatia, et al.
Published: (2022-01-01)

Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
by: Jarir At Thobari
Published: (2021-08-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021-05-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies
by: R.L. Schroeder, et al.
Published: (2014-01-01)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
by: Nicholas J White, et al.
Published: (2020-09-01)

Retinal Toxicity and the Use of Hydroxychloroquine and Chloroquine in the Current Management of COVID-19
by: Romulo N. Aguilar, MD, PhD, et al.
Published: (2020-06-01)

Early detection of the retinal bioelectrical dysfunction in patients treated by chloroquine/hydroxychloroquine
by: Wojciech Lubiński, et al.
Published: (2024-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
by: Muhammad Haroon Aftab, et al.
Published: (2024-01-01)

Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
by: Alessandra Costanza, et al.
Published: (2021-11-01)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
by: Christina B. Klouda, et al.
Published: (2020-09-01)

Knowledge-based assessment of polymorphism in crystal structures involving chloroquine and hydroxychloroquine
by: Samuel Tetteh
Published: (2022-01-01)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
by: Partha Sarathi Biswas, et al.
Published: (2020-09-01)

Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine
by: Peter W. Halcrow, et al.
Published: (2021-02-01)

Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
by: Tangtavorn N, et al.
Published: (2016-11-01)